| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |